Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population

The aims of this study were two-fold: (1) to describe the patterns of comorbid psychiatric diagnosis and psychotropic drug therapy for children enrolled in a Medicaid-managed care program and diagnosed with attention-deficit/hyperactivity disorder (ADHD) in 2000 and (2) to examine child and provider...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of child and adolescent psychopharmacology 2005-02, Vol.15 (1), p.44-56
Hauptverfasser: Radigan, Marleen, Lannon, Peter, Roohan, Patrick, Gesten, Foster
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 56
container_issue 1
container_start_page 44
container_title Journal of child and adolescent psychopharmacology
container_volume 15
creator Radigan, Marleen
Lannon, Peter
Roohan, Patrick
Gesten, Foster
description The aims of this study were two-fold: (1) to describe the patterns of comorbid psychiatric diagnosis and psychotropic drug therapy for children enrolled in a Medicaid-managed care program and diagnosed with attention-deficit/hyperactivity disorder (ADHD) in 2000 and (2) to examine child and provider characteristics associated with psychotropic medication patterns for this population. Multivariate logistic regression models were used to examine correlates of stimulant and seven nonstimulant psychotropic medication classes (alpha-agonists, mood stabilizer/anticonvulsant, antianxiety, standard antipsychotic, atypical antipsychotic, and tricyclic antidepressant (TCA)/other antidepressant and selective serotonin reuptake inhibitor (SSRI) antidepressant). With the exception of conduct disorders (odds ratio, 1.22; 95% confidence interval, 1.06-1.40), comorbid disorders had a significant protective effect (odds ratio less than 1) on dispensing stimulants. After adjusting for covariates, stimulant dispensing was strongly correlated with the interactions of geographic region with race/ethnicity and provider type. Children residing in the upstate New York region had an approximately ten-fold greater chance of being dispensed a stimulant compared to similar children in New York City. Utilizing a mental health provider increased the chance of being dispensed a stimulant by factor of two for children from New York City of any race/ethnicity group. Models predicting nonstimulant drug dispensing were distinct from the stimulant model. After adjusting for covariates, nonstimulant psychotropic medication dispensing was correlated with clinical factors, including comorbid disorder category and use of a mental health provider, as well as notable sociodemographic factors. Complex psychotropic medication and comorbid psychiatric disorder patterns were evident for this low-income population of children with ADHD. The roles of clinical, patient, and provider factors need to be better understood to explain these patterns of stimulant and nonstimulant psychotropic medications dispensed.
doi_str_mv 10.1089/cap.2005.15.44
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67478486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>813503091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-589e9f1262c7db80eb1cf23b8e074905d14b5c57849705bdb7dd0bf389b958473</originalsourceid><addsrcrecordid>eNpdkUtr3DAUhUVpyEyTbLssoovu7Ei2ZEnLMPQFCdkka6GXiQaP5Epyyqzy1yMnA4Wu7uHynXMvHAA-Y9RixMW1UXPbIURbTFtCPoAtppQ1XIjuY9WIkIaSod-ATznvEcL9gIZzsMGUEcw43YKXO2e9UcXHAGdVikshwzEmuOqwrhvrRm98uX46zi4pU_yzL0dofY7JugoGC008xKS9hXM-mievSvKmLoP1a0KGPkAFp_i38aGiDs5xXqa3o5fgbFRTdleneQEef3x_2P1qbu9__t7d3Dam71BpKBdOjLgbOsOs5shpbMau19whRgSiFhNNDWWcCIaotppZi_TYc6EF5YT1F-Dbe-6c4p_F5SIPPhs3TSq4uGQ5MFLNfKjg1__AfVxSqL_JDhEqBvKW1r5DJsWckxvlnPxBpaPESK69yNqLXHuRmEpCquHLKXXRB2f_4aci-ld3F4vh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204596447</pqid></control><display><type>article</type><title>Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Radigan, Marleen ; Lannon, Peter ; Roohan, Patrick ; Gesten, Foster</creator><creatorcontrib>Radigan, Marleen ; Lannon, Peter ; Roohan, Patrick ; Gesten, Foster</creatorcontrib><description>The aims of this study were two-fold: (1) to describe the patterns of comorbid psychiatric diagnosis and psychotropic drug therapy for children enrolled in a Medicaid-managed care program and diagnosed with attention-deficit/hyperactivity disorder (ADHD) in 2000 and (2) to examine child and provider characteristics associated with psychotropic medication patterns for this population. Multivariate logistic regression models were used to examine correlates of stimulant and seven nonstimulant psychotropic medication classes (alpha-agonists, mood stabilizer/anticonvulsant, antianxiety, standard antipsychotic, atypical antipsychotic, and tricyclic antidepressant (TCA)/other antidepressant and selective serotonin reuptake inhibitor (SSRI) antidepressant). With the exception of conduct disorders (odds ratio, 1.22; 95% confidence interval, 1.06-1.40), comorbid disorders had a significant protective effect (odds ratio less than 1) on dispensing stimulants. After adjusting for covariates, stimulant dispensing was strongly correlated with the interactions of geographic region with race/ethnicity and provider type. Children residing in the upstate New York region had an approximately ten-fold greater chance of being dispensed a stimulant compared to similar children in New York City. Utilizing a mental health provider increased the chance of being dispensed a stimulant by factor of two for children from New York City of any race/ethnicity group. Models predicting nonstimulant drug dispensing were distinct from the stimulant model. After adjusting for covariates, nonstimulant psychotropic medication dispensing was correlated with clinical factors, including comorbid disorder category and use of a mental health provider, as well as notable sociodemographic factors. Complex psychotropic medication and comorbid psychiatric disorder patterns were evident for this low-income population of children with ADHD. The roles of clinical, patient, and provider factors need to be better understood to explain these patterns of stimulant and nonstimulant psychotropic medications dispensed.</description><identifier>ISSN: 1044-5463</identifier><identifier>EISSN: 1557-8992</identifier><identifier>DOI: 10.1089/cap.2005.15.44</identifier><identifier>PMID: 15741785</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adolescent ; Adult ; Attention Deficit Disorder with Hyperactivity - drug therapy ; Attention Deficit Disorder with Hyperactivity - epidemiology ; Attention deficit hyperactivity disorder ; Child ; Child, Preschool ; Children &amp; youth ; Comorbidity ; Confidence Intervals ; Drug therapy ; Female ; Humans ; Hyperactivity ; Male ; Managed Care Programs ; Medicaid ; Mental disorders ; Mental Disorders - drug therapy ; Mental Disorders - epidemiology ; Morbidity ; Multivariate Analysis ; New York - epidemiology ; Odds Ratio ; Pharmaceuticals ; Poverty ; Psychotropic Drugs - therapeutic use</subject><ispartof>Journal of child and adolescent psychopharmacology, 2005-02, Vol.15 (1), p.44-56</ispartof><rights>(©) Copyright 2005, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c320t-589e9f1262c7db80eb1cf23b8e074905d14b5c57849705bdb7dd0bf389b958473</citedby><cites>FETCH-LOGICAL-c320t-589e9f1262c7db80eb1cf23b8e074905d14b5c57849705bdb7dd0bf389b958473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15741785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Radigan, Marleen</creatorcontrib><creatorcontrib>Lannon, Peter</creatorcontrib><creatorcontrib>Roohan, Patrick</creatorcontrib><creatorcontrib>Gesten, Foster</creatorcontrib><title>Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population</title><title>Journal of child and adolescent psychopharmacology</title><addtitle>J Child Adolesc Psychopharmacol</addtitle><description>The aims of this study were two-fold: (1) to describe the patterns of comorbid psychiatric diagnosis and psychotropic drug therapy for children enrolled in a Medicaid-managed care program and diagnosed with attention-deficit/hyperactivity disorder (ADHD) in 2000 and (2) to examine child and provider characteristics associated with psychotropic medication patterns for this population. Multivariate logistic regression models were used to examine correlates of stimulant and seven nonstimulant psychotropic medication classes (alpha-agonists, mood stabilizer/anticonvulsant, antianxiety, standard antipsychotic, atypical antipsychotic, and tricyclic antidepressant (TCA)/other antidepressant and selective serotonin reuptake inhibitor (SSRI) antidepressant). With the exception of conduct disorders (odds ratio, 1.22; 95% confidence interval, 1.06-1.40), comorbid disorders had a significant protective effect (odds ratio less than 1) on dispensing stimulants. After adjusting for covariates, stimulant dispensing was strongly correlated with the interactions of geographic region with race/ethnicity and provider type. Children residing in the upstate New York region had an approximately ten-fold greater chance of being dispensed a stimulant compared to similar children in New York City. Utilizing a mental health provider increased the chance of being dispensed a stimulant by factor of two for children from New York City of any race/ethnicity group. Models predicting nonstimulant drug dispensing were distinct from the stimulant model. After adjusting for covariates, nonstimulant psychotropic medication dispensing was correlated with clinical factors, including comorbid disorder category and use of a mental health provider, as well as notable sociodemographic factors. Complex psychotropic medication and comorbid psychiatric disorder patterns were evident for this low-income population of children with ADHD. The roles of clinical, patient, and provider factors need to be better understood to explain these patterns of stimulant and nonstimulant psychotropic medications dispensed.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Attention Deficit Disorder with Hyperactivity - drug therapy</subject><subject>Attention Deficit Disorder with Hyperactivity - epidemiology</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children &amp; youth</subject><subject>Comorbidity</subject><subject>Confidence Intervals</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperactivity</subject><subject>Male</subject><subject>Managed Care Programs</subject><subject>Medicaid</subject><subject>Mental disorders</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental Disorders - epidemiology</subject><subject>Morbidity</subject><subject>Multivariate Analysis</subject><subject>New York - epidemiology</subject><subject>Odds Ratio</subject><subject>Pharmaceuticals</subject><subject>Poverty</subject><subject>Psychotropic Drugs - therapeutic use</subject><issn>1044-5463</issn><issn>1557-8992</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkUtr3DAUhUVpyEyTbLssoovu7Ei2ZEnLMPQFCdkka6GXiQaP5Epyyqzy1yMnA4Wu7uHynXMvHAA-Y9RixMW1UXPbIURbTFtCPoAtppQ1XIjuY9WIkIaSod-ATznvEcL9gIZzsMGUEcw43YKXO2e9UcXHAGdVikshwzEmuOqwrhvrRm98uX46zi4pU_yzL0dofY7JugoGC008xKS9hXM-mievSvKmLoP1a0KGPkAFp_i38aGiDs5xXqa3o5fgbFRTdleneQEef3x_2P1qbu9__t7d3Dam71BpKBdOjLgbOsOs5shpbMau19whRgSiFhNNDWWcCIaotppZi_TYc6EF5YT1F-Dbe-6c4p_F5SIPPhs3TSq4uGQ5MFLNfKjg1__AfVxSqL_JDhEqBvKW1r5DJsWckxvlnPxBpaPESK69yNqLXHuRmEpCquHLKXXRB2f_4aci-ld3F4vh</recordid><startdate>20050201</startdate><enddate>20050201</enddate><creator>Radigan, Marleen</creator><creator>Lannon, Peter</creator><creator>Roohan, Patrick</creator><creator>Gesten, Foster</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050201</creationdate><title>Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population</title><author>Radigan, Marleen ; Lannon, Peter ; Roohan, Patrick ; Gesten, Foster</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-589e9f1262c7db80eb1cf23b8e074905d14b5c57849705bdb7dd0bf389b958473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Attention Deficit Disorder with Hyperactivity - drug therapy</topic><topic>Attention Deficit Disorder with Hyperactivity - epidemiology</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children &amp; youth</topic><topic>Comorbidity</topic><topic>Confidence Intervals</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperactivity</topic><topic>Male</topic><topic>Managed Care Programs</topic><topic>Medicaid</topic><topic>Mental disorders</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental Disorders - epidemiology</topic><topic>Morbidity</topic><topic>Multivariate Analysis</topic><topic>New York - epidemiology</topic><topic>Odds Ratio</topic><topic>Pharmaceuticals</topic><topic>Poverty</topic><topic>Psychotropic Drugs - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Radigan, Marleen</creatorcontrib><creatorcontrib>Lannon, Peter</creatorcontrib><creatorcontrib>Roohan, Patrick</creatorcontrib><creatorcontrib>Gesten, Foster</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Proquest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of child and adolescent psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Radigan, Marleen</au><au>Lannon, Peter</au><au>Roohan, Patrick</au><au>Gesten, Foster</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population</atitle><jtitle>Journal of child and adolescent psychopharmacology</jtitle><addtitle>J Child Adolesc Psychopharmacol</addtitle><date>2005-02-01</date><risdate>2005</risdate><volume>15</volume><issue>1</issue><spage>44</spage><epage>56</epage><pages>44-56</pages><issn>1044-5463</issn><eissn>1557-8992</eissn><abstract>The aims of this study were two-fold: (1) to describe the patterns of comorbid psychiatric diagnosis and psychotropic drug therapy for children enrolled in a Medicaid-managed care program and diagnosed with attention-deficit/hyperactivity disorder (ADHD) in 2000 and (2) to examine child and provider characteristics associated with psychotropic medication patterns for this population. Multivariate logistic regression models were used to examine correlates of stimulant and seven nonstimulant psychotropic medication classes (alpha-agonists, mood stabilizer/anticonvulsant, antianxiety, standard antipsychotic, atypical antipsychotic, and tricyclic antidepressant (TCA)/other antidepressant and selective serotonin reuptake inhibitor (SSRI) antidepressant). With the exception of conduct disorders (odds ratio, 1.22; 95% confidence interval, 1.06-1.40), comorbid disorders had a significant protective effect (odds ratio less than 1) on dispensing stimulants. After adjusting for covariates, stimulant dispensing was strongly correlated with the interactions of geographic region with race/ethnicity and provider type. Children residing in the upstate New York region had an approximately ten-fold greater chance of being dispensed a stimulant compared to similar children in New York City. Utilizing a mental health provider increased the chance of being dispensed a stimulant by factor of two for children from New York City of any race/ethnicity group. Models predicting nonstimulant drug dispensing were distinct from the stimulant model. After adjusting for covariates, nonstimulant psychotropic medication dispensing was correlated with clinical factors, including comorbid disorder category and use of a mental health provider, as well as notable sociodemographic factors. Complex psychotropic medication and comorbid psychiatric disorder patterns were evident for this low-income population of children with ADHD. The roles of clinical, patient, and provider factors need to be better understood to explain these patterns of stimulant and nonstimulant psychotropic medications dispensed.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>15741785</pmid><doi>10.1089/cap.2005.15.44</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1044-5463
ispartof Journal of child and adolescent psychopharmacology, 2005-02, Vol.15 (1), p.44-56
issn 1044-5463
1557-8992
language eng
recordid cdi_proquest_miscellaneous_67478486
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Adolescent
Adult
Attention Deficit Disorder with Hyperactivity - drug therapy
Attention Deficit Disorder with Hyperactivity - epidemiology
Attention deficit hyperactivity disorder
Child
Child, Preschool
Children & youth
Comorbidity
Confidence Intervals
Drug therapy
Female
Humans
Hyperactivity
Male
Managed Care Programs
Medicaid
Mental disorders
Mental Disorders - drug therapy
Mental Disorders - epidemiology
Morbidity
Multivariate Analysis
New York - epidemiology
Odds Ratio
Pharmaceuticals
Poverty
Psychotropic Drugs - therapeutic use
title Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A57%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medication%20patterns%20for%20attention-deficit/hyperactivity%20disorder%20and%20comorbid%20psychiatric%20conditions%20in%20a%20low-income%20population&rft.jtitle=Journal%20of%20child%20and%20adolescent%20psychopharmacology&rft.au=Radigan,%20Marleen&rft.date=2005-02-01&rft.volume=15&rft.issue=1&rft.spage=44&rft.epage=56&rft.pages=44-56&rft.issn=1044-5463&rft.eissn=1557-8992&rft_id=info:doi/10.1089/cap.2005.15.44&rft_dat=%3Cproquest_cross%3E813503091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204596447&rft_id=info:pmid/15741785&rfr_iscdi=true